A perovskite nanozyme, its preparation method and application
By preparing perovskite-type calcium manganate nanoparticles, the problems of ease of preparation and improved enzyme activity of nanozymes have been solved, achieving ultra-fast catalytic reactions and tumor-targeted therapy effects, and making them suitable for the detection of reducing substances and enzyme-linked immunosorbent assay (ELISA).
Patent Information
- Application Number
- CN202410332619.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-03-22
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2044-03-22
AI Technical Summary
Existing nanozymes have shortcomings in terms of ease of preparation, improvement of enzyme activity, and environmental adaptability. Furthermore, natural enzymes have poor stability under non-physiological conditions, which limits their widespread application.
A perovskite-type calcium manganate nanoparticle (CaMnO3) was prepared by sol-gel method and high-temperature solid-state sintering method. It has oxidase-like and peroxidase-like activities, can catalyze color reaction in a very short time, and maintain high enzyme activity in the pH range of 3.5-7.4.
It achieves ultrafast catalytic reactions, exhibits excellent long-term room temperature stability and pH responsiveness, is suitable for the detection of reducing substances and enzyme-linked immunosorbent assay (ELISA), and has significant targeted anti-tumor effects in the tumor microenvironment.
Smart Images

Figure CN118237009B_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of enzyme catalysis technology, specifically to an ultrafast perovskite nanozyme with both oxidase-like and peroxidase-like activities, its preparation method, and its applications. Background Technology
[0002] Enzymes are important biological catalysts that participate in various biological functions, such as energy metabolism, signal transduction, and cell physiology, by catalyzing substrate reactions. Enzymatic reactions are characterized by high catalytic efficiency and high substrate specificity. Due to their crucial role in biological processes and metabolism, enzymes are widely used in biological applications, showing promising prospects in fields such as the food industry, pharmaceutical processes, and biomedicine.
[0003] Since most natural enzymes are proteins, their reactions require suitable temperature and pH conditions. However, under non-physiological conditions such as acids, alkalis, organic solvents, heavy metal salts, high temperatures, ultraviolet light, and violently agitated acids, proteins easily denature and lose their activity, leading to instability in their catalytic performance. The abundance of natural enzymes in living organisms is very low, while in vitro synthesis and purification are very costly, thus greatly limiting the widespread application of natural enzymes.
[0004] Nanozymes are a class of nanomaterials with catalytic properties. Compared to natural enzymes, nanozymes exhibit higher stability, activity, and selectivity, thus possessing broad application potential in catalytic reactions. In 1997, a fullerene derivative was discovered to possess superoxide dismutase (SOD) activity, becoming the first inorganic nanozyme discovered. To date, dozens of inorganic nanomaterials with different catalytic activities have been discovered. Examples include Fe3O4 nanoparticles, gold nanoparticles, graphene oxide (GO) nanosheets, and polypyrrole nanoparticles with peroxidase-like activities; Pt nanoparticles, palladium nanomaterials, cerium oxide, and manganese dioxide nanoparticles with catalase (CAT)-like and superoxide dismutase (SOD)-like activities; and V2O5 nanowires with glutathione peroxide (GPx)-like activities.
[0005] Perovskites are a class of compounds with an ABX3 structure. Current research has revealed that some perovskites possess different catalytic activities. For example, perovskite LaFeO3 nanocrystals exhibit multiple enzymatic activities, including those resembling oxidases, peroxidases, glutathione peroxidase, and catalases; and CsPbX3 perovskite nanocrystals exhibit peroxidase-like activity.
[0006] Compared to biological enzymes, nanozymes possess advantages such as strong catalytic activity, high stability, low preparation cost, good durability, and the ability to be mass-produced. Furthermore, some nanozymes can catalyze non-natural biological processes, such as bioorthogonal catalysis. Based on these superior properties, nanozymes have been widely applied in fields such as biosensing, environmental remediation, disease diagnosis and treatment, neuroprotection, stem cell growth, antibacterial activity, and antioxidant activity.
[0007] Although nanozymes have made some research progress, they still have great potential for development in terms of ease of preparation, improvement of enzyme activity, improvement of enzyme reaction sensitivity, and applicability in different environments. Summary of the Invention
[0008] Based on the aforementioned problems, the present invention aims to provide a perovskite nanozyme, its preparation method, and its applications. This perovskite nanozyme possesses both oxidase-like and peroxidase-like activities, exhibits ultra-fast reaction characteristics, and has potential application value in fields such as reducing substance detection and enzyme-linked immunosorbent assay (ELISA). Due to its pH responsiveness and ability to produce various free radicals (including hydroxyl radicals and superoxide radicals), it also has significant tumor-targeted therapeutic effects.
[0009] In a first aspect, the present invention provides a perovskite nanozyme, specifically a nanozyme that utilizes its oxidase-like activity and / or peroxidase-like activity to be used as an oxidase and / or peroxidase. The perovskite nanozyme is a perovskite-type calcium manganate nanoparticle material (CaMnO3, denoted as CMO), which has a cubic perovskite structure and possesses both oxidase-like and peroxidase-like activities.
[0010] The perovskite nanozyme of this invention possesses oxidase (OXD) activity, which can catalyze the generation of cytotoxic superoxide anions (·O2) from oxygen. 2- The oxidation of 3,3',5,5'-tetramethylbenzidine hydrochloride (TMB) produces a color reaction.
[0011] The perovskite nanozyme of this invention has peroxidase-like activity, which can catalyze the generation of cytotoxic hydroxyl radicals (·OH) from hydrogen peroxide, and oxidize TMB to produce a color reaction.
[0012] Testing revealed that the perovskite nanozyme of the present invention exhibits ultra-fast reaction characteristics. As an oxidase, it can catalyze a color reaction of TMB in an extremely short time (1 second), and as a peroxidase, it can catalyze a color reaction of TMB by oxidizing peroxide in an extremely short time (1 second).
[0013] In addition, when the perovskite nanozyme of the present invention is used as a peroxidase, the pH value will affect the enzyme activity. The enzyme activity is better in the pH range of 3.5-7.4, while the enzyme activity is highest at pH 4.
[0014] When the perovskite nanozyme of the present invention is used as an oxidase, the pH value will affect the enzyme activity. The enzyme activity is better in the pH range of 3.5-7.4, and the enzyme activity is highest at pH 3.5.
[0015] Specifically, the perovskite nanozyme of the present invention has a particle size of 100~300 nm.
[0016] Secondly, the present invention also provides a method for preparing the above-mentioned perovskite nanozyme, which involves reacting calcium nitrate, manganese nitrate, citric acid and ethanol via a sol-gel method, followed by high-temperature solid-state sintering to obtain perovskite nanoparticle materials, namely perovskite nanozymes.
[0017] The preparation method of the perovskite nanozyme of the present invention specifically includes the following steps: Step 1: Dissolve calcium nitrate and manganese nitrate in water, then add citric acid, mix well, and then add ethanol to obtain the reaction solution; Step 2: Place the reaction solution obtained in Step 1 in a water bath, evaporate the ethanol, and obtain a gel; Step 3: Dry the gel obtained in step 2 in an oven to form a fluffy honeycomb precursor; Step 4: Take out the honeycomb precursor obtained in Step 3, crush and grind it into precursor powder; place the precursor powder in a muffle furnace for calcination to obtain perovskite nanoparticle material, and obtain perovskite nanozyme.
[0018] Specifically, in step 1, citric acid is first dissolved in water, and then the citric acid solution is added dropwise to a mixed solution of calcium nitrate and manganese nitrate while stirring continuously during the addition process; in the reaction solution obtained in step 1 after adding ethanol, the mass concentration of calcium nitrate is 2.36-2.37%, the mass concentration of manganese nitrate is 1.7-1.8%, the mass concentration of citric acid is 7-8%, and the volume concentration of ethylene glycol is 5%.
[0019] Specifically, in step 2, the reaction solution obtained in step 1 is subjected to a water bath at 80°C; in step 3, the gel obtained in step 2 is dried in an oven at 150°C for 5 hours.
[0020] Specifically, in step 4, the precursor powder is calcined in a muffle furnace at 500°C for 4 hours and at 900°C for 5 hours. The time taken for the muffle furnace to rise from 0°C to 500°C is 1 hour, then the muffle furnace is maintained at 500°C for 4 hours, then the time taken for the muffle furnace to rise from 500°C to 900°C is 1 hour, then the muffle furnace is maintained at 900°C for 4 hours, and then the temperature is allowed to drop naturally to room temperature.
[0021] Thirdly, the present invention provides the application of the above-mentioned perovskite nanozyme in the detection of reducing substances.
[0022] Fourthly, the present invention provides the application of the above-mentioned perovskite nanozyme in enzyme-linked immunosorbent assay (ELISA).
[0023] Fifthly, the present invention provides the application of the above-mentioned perovskite nanozyme in the preparation of tumor therapeutic drugs.
[0024] The beneficial effects of this invention are as follows: The perovskite nanozyme of this invention is a perovskite-type calcium manganate composite material that combines oxidase-like and peroxidase-like activities. It is a multifunctional nanozyme that, compared with other existing nanozymes, has ultrafast reaction characteristics. It can catalyze the colorimetric reaction of 3,3',5,5'-tetramethylbenzidine hydrochloride and the oxidation of 3,3',5,5'-tetramethylbenzidine hydrochloride by peroxide in a very short time. It also has excellent long-term room temperature stability and has important application value in the fields of rapid detection of reducing substances and enzyme-linked immunosorbent assay (ELISA). In addition, due to its excellent pH responsiveness and sonosensitive properties, it can be activated in the weakly acidic microenvironment of tumors and can be further activated by ultrasound to generate a variety of free radicals, thus exhibiting significant targeted anti-tumor effects. Attached Figure Description
[0025] Figure 1 a is a TEM image of the CMO nanozyme prepared in Example 1. Figure 1 b is an HRTEM image of the CMO nanozyme prepared in Example 1. Figure 1 c is the XRD pattern of the CMO nanozyme prepared in Example 1. Figure 1 d is a schematic diagram of the crystal structure of the CMO nanozyme prepared in Example 1. Figure 1 e is the elemental mapping diagram of the CMO nanozyme prepared in Example 1. Figure 1 f is the spectral measurement diagram and high-resolution XPS spectrum of the CMO nanozyme prepared in Example 1. Figure 2 This is a graph showing the UV absorption at 652 nm as a function of pH when the CMO nanozyme prepared in Example 1 reacts with TMB in the presence of H2O2. Figure 3This is a graph showing the UV absorption at 652 nm of the CMO nanozyme prepared in Example 1 reacting with TMB in the presence of H2O2 as a function of nanozyme concentration. Figure 4 The graph shows the UV absorption at 652 nm over time for CMO nanozymes and TMB at different concentrations in the presence of H2O2. Figure 5 The graph shows the UV absorption at 652 nm over time for CMO nanozymes and different concentrations of TMB in the presence of H2O2. Figure 6 The graph shows the UV absorption curves of CMO nanozymes and TMB at 652 nm over time under different concentrations of H2O2. Figure 7 This is a graph showing the UV absorption at 652 nm of the CMO nanozyme and TMB prepared in Example 1 as a function of pH value. Figure 8 This is a graph showing the UV absorption of the CMO nanozyme prepared in Example 1 at 652 nm as a function of nanozyme concentration, along with the TMB concentration. Figure 9 This is a graph showing the results of measuring the hydroxyl radicals generated by the CMO nanozyme prepared in Example 1; Figure 10 This is a graph showing the measurement results of superoxide anion production by the CMO nanozyme prepared in Example 1; Figure 11 This is a line graph showing the weight changes of mice during treatment in the evaluation test of the antitumor performance of the perovskite nanozyme of this invention. Figure 12 This is a line graph showing the changes in tumor volume in tumor-bearing mice during treatment, used in the evaluation test of the antitumor performance of the perovskite nanozyme of this invention. Figure 13 This is a graph showing the weight of tumors in each group of tumor-bearing mice after treatment, during the evaluation test of the antitumor performance of the perovskite nanozyme of the present invention. Figure 14 These are photographs of tumors in tumor-bearing mice after treatment and corresponding line graphs showing changes in tumor weight, used in the evaluation test of the anti-tumor performance of the perovskite nanozyme of this invention. Detailed Implementation
[0026] To better explain the present invention, detailed descriptions of its embodiments are provided, and the main content of the invention is further clarified in conjunction with specific examples. However, the content of the present invention is not limited to the following embodiments. Where specific techniques or conditions are not specified in the embodiments, they are performed according to the techniques or conditions described in the literature in the field or according to the product instructions. Reagents or instruments used, unless otherwise specified, are all commercially available conventional products. Example
[0027] Preparation of perovskite nanozymes: Add 2.3615g Ca(NO3)2·4H2O and 1.7895g Mn(NO3)2 to 50mL of deionized water and stir until completely dissolved; weigh 7.6852g citric acid, add it to 40mL of deionized water, stir until completely dissolved, and then add it dropwise to the mixture of manganese nitrate and calcium nitrate, stirring continuously during the dropwise addition process; Then, 5 ml of ethylene glycol was added to the above solution, mixed evenly, and placed in an 80°C water bath to evaporate the solvent and obtain a gel. The gel was dried in an oven at 150°C for 5 hours to form a fluffy honeycomb precursor. The honeycomb precursor was removed, crushed and ground into powder. The powder was then placed in a muffle furnace and calcined at 500°C for 4 hours, and then calcined at 900°C for 5 hours to obtain perovskite oxide nanoparticles, namely perovskite nanozymes (denoted as CMO nanozymes).
[0028] Performance Testing I. Basic Performance Testing (1) The CMO nanozyme obtained in Example 1 was characterized by TEM, and the results are as follows: Figure 1 As shown in a.
[0029] Results analysis: Figure 1 Transmission electron microscopy (TEM) images of a confirmed the nanoparticle morphology of CMO perovskite nanoparticles.
[0030] (2) The CMO nanozyme obtained in Example 1 was characterized by HRTEM, and the results are as follows: Figure 1 As shown in b.
[0031] Results analysis: From Figure 1 As can be seen in b, the high-resolution TEM (HRTEM) image shows lattice fringes of 0.264 nm, which is consistent with the (220) atomic plane of CaMnO3.
[0032] (3) The CMO nanozyme obtained in Example 1 was subjected to X-ray diffraction (XRD) analysis to study its crystallinity and crystal structure. The results are as follows: Figure 1 As shown in c.
[0033] Results analysis: From Figure 1 As can be seen from c, the peaks of 2θ for 23.84, 33.96, 48.8, 60.78 and 71.4 belong to the (200), (220), (400), (422) and (440) planes of CMO (JCPDS card 03-0830), indicating the cubic perovskite structure of CMO.
[0034] (4) Elemental mapping analysis was performed on the CMO nanozyme obtained in Example 1, and the results are as follows: Figure 1 As shown in f.
[0035] Results analysis: Figure 1 d and e are ball-and-bar models and polyhedral models of CMO nanoparticles based on crystallographic information files, containing Ca-O hexahedrons and Mn-O octahedra. Elemental mapping analysis test results are from... Figure 1 As can be seen from f, Ca, Mn and O elements are evenly distributed.
[0036] (5) The surface oxidation state of the CMO nanoparticles was detected by X-ray photoelectron spectroscopy (XPS) measurement and analysis of the CMO nanozyme obtained in Example 1. The results are as follows: Figure 1 As shown in g.
[0037] Results analysis: From Figure 1 As can be seen from g, the high-resolution spectrum of Ca 2p shows two peaks at 345.3 eV (Ca 2p3 / 2) and 348.8 eV (Ca 2p1 / 2), with a binding band gap of 3.5 eV, indicating that calcium ions exist in the form of divalent oxides. For the Mn 2p spectrum, the binding band gap between Mn 2p3 / 2 and Mn 2p1 / 2 is 11.5 eV. The peaks with binding energies of 641.9 eV / 653.9 eV and 643.6 eV / 656.5 eV correspond to Mn 2p3 / 2 and Mn 2p1 / 2, respectively. 3+ and Mn 4+ The presence of oxygen. In the high-resolution O 1s spectrum, the asymmetric peaks can be represented as lattice oxygen (528.8 eV), oxygen vacancies (529.8 eV), and surface adsorbed oxygen (531.8 eV), respectively.
[0038] II. Peroxidase-like activity assay of perovskite nanozymes 3,3′,5,5′-Tetramethylbenzidine (TMB) is a reagent that can detect the generation of hydroxyl radicals. Upon contact with hydroxyl radicals, TMB in solution changes from colorless to blue, forming TMB oxide (TMBox). Nanozymes with peroxidase-like activity can oxidize TMB to TMBox in the presence of H₂O₂. Therefore, the absorbance of TMBox at 652 nm is used as an indicator to detect the peroxidase-like activity of the nanozymes involved in this invention.
[0039] (1) Determination and analysis of the relationship between pH value and reaction degree: The sample solution contained 40 μg / mL CMO nanozyme, 0.4 mM TMB, and 10 nM H2O2. The ·OH generation capacity of CMO nanozyme in different pH environments was evaluated. The results are as follows: Figure 2As shown in the figure (UV spectra of the sample solution at wavelengths of 500 nm-800 nm), the absorbance increases with decreasing pH in the pH range of 3.5-7.4, reaching its highest value at pH 4.0. This indicates that the ·OH generation ability of CMO nanozymes is strongest at pH 4.0.
[0040] (2) Determination and analysis of the relationship between enzyme concentration and reaction extent: Figure 3 The UV spectra of the reaction sample solutions at various nanozyme concentrations are shown in the figure (the curves in the figure correspond to 1 mg / mL, 0.8 mg / mL, 0.6 mg / mL, 0.4 mg / mL, 0.2 mg / mL and 0 mg / mL from top to bottom). As can be seen from the figure, the absorbance increases with increasing enzyme concentration.
[0041] (3) Determination and analysis of the relationship between reaction time and reaction extent: The experimental sample solution contained CMO nanozyme, TMB, and H2O2. The ·OH generation capacity of CMO nanozyme was evaluated. The UV-Vis absorption of TMBox at 652 nm was recorded every 30 seconds for 10 min. The results are as follows: Figure 4 (The sample solutions contained different concentrations of CMO nanozyme, 0.4 mM TMB and 100 nM H2O2, respectively.) Figure 5 (The sample solutions contained different concentrations of TMB, 20 μg / mC LMO nanozyme, and 100 mM H2O2, respectively.) Figure 6 (The sample solutions contained different concentrations of H2O2, 0.4 mM TMB, and 20 μg / mL CMO nanozyme.) As shown, within the test time range, the absorbance of the solution at 652 nm increased, and the absorbance almost reached its maximum within 10 seconds (the time of the first detection). This indicates that TMBox is generated the instantaneously upon contact between CMO nanozyme and TMB, proving that the perovskite nanozyme has peroxidase-like activity and very high sensitivity.
[0042] III. Oxidase-like Activity Test of Perovskite Nanozymes 3,3′,5,5′-Tetramethylbenzidine (TMB) is a reagent that can detect the generation of hydroxyl radicals. Upon contact with hydroxyl radicals, TMB in solution changes from colorless to blue, forming TMB oxide (TMBox). Nanozymes with oxidase-like activity can oxidize TMB to TMBox. Therefore, the absorbance of TMBox at 652 nm is used as an indicator to detect the oxidase-like activity of the nanozymes involved in this invention.
[0043] (1) Determination and analysis of the relationship between pH value and reaction degree: The sample solution contained 20 μg / mL CMO nanozyme and 0.4 mM TMB. The ·OH generation capacity of CMO nanozyme in different pH environments was evaluated. The results are as follows: Figure 7 As shown in the figure (UV spectra of the sample solution at wavelengths of 500 nm-800 nm), the absorbance increases with decreasing pH in the pH range of 3.5-7.4, reaching its highest value at pH 3.5. This indicates that the ·OH generation ability of CMO nanozymes is strongest at pH 3.5.
[0044] (2) Determination and analysis of the relationship between enzyme concentration and reaction extent: Figure 8 The UV spectra of the reaction sample solutions at various nanozyme concentrations are shown in the figure (the curves in the figure correspond to 2.8 μg / mL, 2.4 μg / mL, 2.0 μg / mL, 1.6 μg / mL, 0.8 μg / mL, 0.4 μg / mL, and 0 μg / mL from top to bottom). As can be seen from the figure, the absorbance increases with increasing enzyme concentration.
[0045] (3) Determination and analysis of the relationship between reaction time and reaction extent: The experimental sample solution contained nanozyme and TMB. The ·OH generation ability of the perovskite nanozyme was evaluated. The UV-Vis absorption of TMBox at 652 nm was recorded every 10 seconds for 10 min. Figure 8 The curves, from top to bottom, correspond to 2.8 μg / mL, 2.4 μg / mL, 2.0 μg / mL, 1.6 μg / mL, 0.8 μg / mL, 0.4 μg / mL, and 0 μg / mL, respectively. Within the testing time range, the absorbance of the solution at 652 nm increased, reaching almost the maximum absorbance within 10 seconds (the time of the first detection), indicating that TMBox is generated instantaneously upon contact between the CMO nanozyme and TMB. These experimental results demonstrate that the perovskite nanozyme possesses oxidase activity and exhibits very high sensitivity.
[0046] IV. Ultrasonic Activation Test of Perovskite Nanozymes Typically, oxidase-like and peroxidase-like activities arise from the generation of free radicals. We used electron paramagnetic resonance (EPR) technology to test the nanozyme involved in this invention. The experiment utilized EPR to capture free radicals, specifically hydroxyl radicals and superoxide anions. The specific measurement steps are as follows: (1) Hydroxyl radicals: 90 μL PBS (pH 6.5), 10 μL nanozyme solution (5 mg / mL), 10 μL H2O2 (10 M), and 4 μL DMPO solution were added, 1 w / cm2 The sample was sonicated for 3 minutes, then aspirated into a capillary tube and then placed into a sample tube for testing. (2) Superoxide anion: Take 10 μL of nanozyme solution (5 mg / mL), add 50 μL of methanol, add 4 μL of DMPO solution, 1 w / cm 2 The sample was sonicated for 3 minutes, then aspirated into a capillary tube and then placed into a sample tube for testing. The results are as follows Figure 9-10 As shown ( Figure 9 The graph shows the results of the hydroxyl radical determination. Figure 10 The figure shows the results of superoxide anion determination. As can be seen from the figure, the nanozyme involved in this invention can generate two different free radicals after ultrasonic activation: hydroxyl radical and superoxide anion.
[0047] V. Antitumor performance test This embodiment uses a tumor-bearing mouse model to investigate the antitumor effect of the CMO nanozyme prepared in Example 1. The specific procedure is as follows: First, a 4T1 tumor model is established. The CMO nanozyme is injected via tail vein, with nude mice injected only with saline as a blank control. After injection, at specific time intervals, 1 W / cm² of the enzyme is administered to the tumor site. 2 The mice were treated with ultrasound irradiation for 10 minutes. After the ultrasound irradiation, the weight and tumor volume of the nude mice were observed and measured daily. After treatment, the tumor-bearing nude mice were euthanized, the tumors were removed, and weighed.
[0048] Figure 11 The image shows the weight changes in tumor-bearing mice during CMO nanozyme treatment. No significant weight change was observed in the mice during treatment, indicating that CMO nanozyme has good biocompatibility and no obvious toxicity to mice. Figure 12 The study investigated the changes in tumor volume growth in tumor-bearing mice during CMO nanozyme treatment. The results showed that, compared with the control group, the mice receiving intravenous injection of CMO nanozyme combined with ultrasound (US) treatment had the slowest tumor volume growth rate, indicating that the CMO nanozyme prepared in Example 1 combined with US treatment has a significant tumor-inhibiting effect. Figure 13 The tumor weight of tumor-bearing mice after CMO nanozyme treatment was measured. The results showed that, compared with the control group, the mice that received intravenous injection of CMO nanozyme combined with US treatment had the smallest tumor weight, indicating that the nanozyme prepared in Example 1 combined with US treatment has a significant tumor-suppressing effect. Figure 14The images show tumor photographs taken from tumor-bearing mice after treatment and tumor growth curves for individual mice in each group. From the photographs, the tumor volume of mice receiving intravenous injection of CMO nanozyme combined with US treatment was significantly smaller than that of other groups. The tumor growth curves show that the tumor growth rate did not differ significantly among the groups, but the tumor growth rate in the group receiving intravenous injection of CMO nanozyme combined with US treatment was significantly lower than that in other groups. These experimental results demonstrate that the perovskite nanozyme of this invention has a significant targeted anti-tumor effect.
[0049] The embodiments described above provide a detailed explanation of the technical solutions of the present invention. It should be understood that the above descriptions are only specific embodiments of the present invention and are not intended to limit the present invention. It should be noted that for those skilled in the art, various changes and modifications can be made without departing from the spirit and scope of the present invention, and these changes and modifications should also be considered within the protection scope of the present invention.
Claims
1. A perovskite nanozyme, characterized in that, This refers to the application of perovskite nanozymes as enzymes by utilizing their enzymatic activity. The perovskite nanozymes are perovskite-type calcium manganate nanoparticle materials with a cubic perovskite structure, possessing both oxidase-like and peroxidase-like activities. The perovskite nanozyme has a particle size of 100~300 nm; The preparation method of the perovskite nanozyme specifically includes the following steps: Step 1: Dissolve calcium nitrate and manganese nitrate in water, then add citric acid, mix well, and then add ethylene glycol to obtain the reaction solution; Step 2: Place the reaction solution obtained in Step 1 in a water bath, evaporate the ethylene glycol, and obtain a gel; Step 3: Dry the gel obtained in step 2 in an oven to form a fluffy honeycomb precursor; Step 4: Take out the honeycomb precursor obtained in Step 3, crush and grind it into precursor powder; calcine the precursor powder in a muffle furnace to obtain perovskite nanoparticle material, and obtain perovskite nanoenzyme. In step 1, citric acid is first dissolved in water, and then the citric acid solution is added dropwise to a mixed solution of calcium nitrate and manganese nitrate while continuously stirring. In the reaction solution obtained in step 1, the mass concentration of calcium nitrate is 2.36-2.37%, the mass concentration of manganese nitrate is 1.7-1.8%, the mass concentration of citric acid is 7-8%, and the volume concentration of ethylene glycol is 5%. The reaction solution obtained in step 1 is placed in a water bath at 80°C; in step 3, the gel obtained in step 2 is dried in an oven at 150°C for 5 hours. In step 4, the precursor powder is calcined in a muffle furnace at 500°C for 4 hours and at 900°C for 5 hours. The time taken for the muffle furnace to rise from 0°C to 500°C is 1 hour, then the muffle furnace is maintained at 500°C for 4 hours, then the time taken for the muffle furnace to rise from 500°C to 900°C is 1 hour, then the muffle furnace is maintained at 900°C for 4 hours, and then the temperature is allowed to drop naturally to room temperature.
2. The application of the perovskite nanozyme according to claim 1 in the preparation of reagents for detecting reducing substances.
3. The application of the perovskite nanozyme according to claim 1 in the preparation of enzyme-linked immunosorbent assay (ELISA) reagents.
4. The application of the perovskite nanozyme according to claim 1 in the preparation of tumor therapeutic drugs.
